Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term: an overview of systematic reviews

Archivos

Perez_Effi2021.pdf (2.58 MB)

Fecha

2021

Formato del documento

Articulo

Colecciones

Artículos investigadores UV
7
1
Gestores bibliográficos
MendeleyEndNoteBibTeXCSV

Autores

Santero, M. , Pérez-Bracchiglione, J. , Acosta-Dighero, R. , Meade, A.G. , Antequera, A. , Auladell-Rispau, A. , Quintana, M.J. , C. Requeijo, C. , Rodríguez-Grijalva, G. , Salas-Gama, K. , Dorantes-Romandia, R. , Salazar, J. , Solà, I. , Urrútia, G. , Bonfill Cosp, X.

Profesor Guía

ORCID Autor

Título de la revista

ISSN de la revista

Título del volumen

Editor

Biomed Central

Ubicación

ISBN

ISSN

item.page.issne

DOI

https://doi.org/10.1186/s12885-021-08330-5

URI

http://repositoriobibliotecas.uv.cl/handle/uvscl/7492

Facultad

Facultad de Medicina

Departamento o Escuela

Centro Interdisciplinario de Estudios en Salud (CIESAL)

Determinador

Recolector

Especie

Nota general

Resumen

Background: Esophageal and gastric cancers are a significant public health problem worldwide, with most patients presenting with advanced-stage disease and, consequently, poor prognosis. Systemic onco...

Descripción

Lugar de Publicación

Auspiciador

Palabras clave

ESOPHAGEAL CANCER , GASTRIC CANCER , ANTINEOPLASTIC AGENTS , BIOLOGICAL THERAPY , MOLECULAR TARGETED THERAPY , IMMUNOTHERAPY , REVIEW LITERATURE AS TOPIC , SYSTEMATIC REVIEWS

Licencia

© The Author(s). 2021 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

URL Licencia

Estadísticas de uso
10,80,50,30
Agosto2025
Septiembre2025
Octubre2025
Noviembre2025
Diciembre2025
Enero2026
Febrero2026
Página completa del ítem